Biomarin Pharmaceutical (BMRN) Gross Profit Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
411.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.16% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Biomarin Pharmaceutical |
10.52 Bn |
8.29 Bn |
571.21 Mn |
7.41% |
| Date | Value |
|---|
| Mar 31, 2026 |
7.41% |
| Dec 31, 2025 |
15.28% |
| Sep 30, 2025 |
17.80% |
| Jun 30, 2025 |
18.03% |
| Mar 31, 2025 |
13.84% |
| Dec 31, 2024 |
22.80% |
| Sep 30, 2024 |
22.23% |
| Jun 30, 2024 |
15.79% |
| Mar 31, 2024 |
12.70% |
| Dec 31, 2023 |
15.96% |
| Sep 30, 2023 |
16.32% |
| Jun 30, 2023 |
11.91% |
| Mar 31, 2023 |
5.67% |
| Dec 31, 2022 |
2.92% |
| Sep 30, 2022 |
2.23% |
| Jun 30, 2022 |
9.79% |
| Mar 31, 2022 |
8.90% |
| Dec 31, 2021 |
5.86% |
| Sep 30, 2021 |
-0.82% |
| Jun 30, 2021 |
8.44% |
